BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36929506)

  • 1. RNA modifications in hematological malignancies.
    Jin Z; MacPherson K; Liu Z; Vu LP
    Int J Hematol; 2023 Jun; 117(6):807-820. PubMed ID: 36929506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine in hematological malignancies: a concise review.
    Wang WJ; Xu TT; Bao J
    Curr Opin Hematol; 2023 Jan; 30(1):4-13. PubMed ID: 36165537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of N
    Zhao Y; Peng H
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.
    Yao L; Yin H; Hong M; Wang Y; Yu T; Teng Y; Li T; Wu Q
    Leukemia; 2021 May; 35(5):1243-1257. PubMed ID: 33767371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of RNA N
    Zheng X; Gong Y
    Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA modifications in hematopoietic malignancies: a new research frontier.
    Qing Y; Su R; Chen J
    Blood; 2021 Aug; 138(8):637-648. PubMed ID: 34157073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
    Barbarotto E; Calin GA
    Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Modifications in Hematologic Malignancies.
    Li Y; Tian W; Zhang H
    Cancer Treat Res; 2023; 190():181-207. PubMed ID: 38113002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research Progress of m6A Methylation Modification in Hematological Tumors--Review].
    Li F; Yang FF; Xu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1607-1611. PubMed ID: 36208274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functions and clinical significance of circRNAs in hematological malignancies.
    Zhou X; Zhan L; Huang K; Wang X
    J Hematol Oncol; 2020 Oct; 13(1):138. PubMed ID: 33069241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of copy number variations of BS69 in multiple types of hematological malignancies.
    Yang H; Zhang C; Zhao X; Wu Q; Fu X; Yu B; Shao Y; Guan M; Zhang W; Wan J; Huang X
    Ann Hematol; 2010 Oct; 89(10):959-64. PubMed ID: 20425112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between microRNA-155 and hematological malignancies].
    Xue H; Hua LM; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA methylation in mammalian development and cancer.
    Song P; Tayier S; Cai Z; Jia G
    Cell Biol Toxicol; 2021 Dec; 37(6):811-831. PubMed ID: 34272618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA modification orchestrates cancer stem cell fate decisions.
    Liang W; Lin Z; Du C; Qiu D; Zhang Q
    Mol Cancer; 2020 Feb; 19(1):38. PubMed ID: 32101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematological malignancies: role of miRNAs and their in silico aspects.
    Omer A; Yadav NK; Singh P; Singh RK
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The research progress of circular RNAs in hematological malignancies.
    Ji T; Chen Q; Tao S; Shi Y; Chen Y; Shen L; Wang C; Yu L
    Hematology; 2019 Dec; 24(1):727-731. PubMed ID: 31581903
    [No Abstract]   [Full Text] [Related]  

  • 18. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitranscriptomics: regulation of mRNA metabolism through modifications.
    Peer E; Rechavi G; Dominissini D
    Curr Opin Chem Biol; 2017 Dec; 41():93-98. PubMed ID: 29125941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances of research on demethylation therapy for hematologic malignancies].
    Chen CH; Yang JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1394-8. PubMed ID: 19840491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.